• 1
    Martina BEE, Koraka P, Osterhaus ADME. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4): 564581.
  • 2
    Martin JL San, Brathwaite O, Zambrano B, Solorzano JO, Bouckenooghe A, Dayan GH, Guzman MG. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg. 2010;82(1): 128135.
  • 3
    Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6(2): 118124.
  • 4
    Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma‘roef C, Erlin S, Porter KR, Halstead SB. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. Studies in 1995–1996. Am J Trop Med Hyg. 1999;61(3): 412419.
  • 5
    Thomas L, Verlaeten O, Cabie A, Kaidomar S, Moravie V, Martial J, Najioullah F, Plumelle Y, Fonteau C, Dussart P, Cesaire R. Influence of the dengue serotype, previous dengue infection, and plasma viral load on clinical presentation and outcome during a dengue-2 and dengue-4 co-epidemic. Am J Trop Med Hyg. 2008; 78(6): 990998.
  • 6
    Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol *. Pediatric Critical Care Medicine 2005; 6(4): 412419.
  • 7
    Zhao Y, Brasier AR. Methods for biomarker verification and assay development. Current Proteomics. 2011; 8: 138152.
  • 8
    Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, Vallejo E, Madrid C, Aguayo N, et al. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis. 2010; 4(8): e787.
  • 9
    Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Geneva : World Health Organization; 1997: 1223.
  • 10
    Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992; 30(3): 545551.
  • 11
    Jamaluddin M, Wiktorowicz JE, Soman KV, Boldogh I, Forbus J, Spratt H, Garofalo RP, Brasier AR. Role of peroxiredoxin-1 and −4 in protection of RSV-induced cysteinyl-oxidation of nuclear cytoskeletal proteins. J Virol. 2010; 84: 95339545.
  • 12
    Pretzer EP, Wiktorowicz JE. Saturation fluorescence labeling of proteins for proteomic analyses. Anal Biochem. 2008; 374: 250262.
  • 13
    Turck CW, Falick AM, Kowalek JA, Lane WS, Lilley KS, Phinney BS, Weintraub ST, Wikowska HE, Yates NA. ABRF-PRG06: Relative Protein Quantification. Long Beach , CA : Association of Biomolecular Resource Facilities; 2006.
  • 14
    Miseta A, Csutora P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol. 2000; 17: 12321239.
  • 15
    Dowsey AW, Morris JS, Gutstein HB, Yang GZ. Informatics and statistics for analyzing 2-D gel electrophoresis images. Methods Mol Biol. 2010; 604: 239255.
  • 16
    Karp NA, Feret R, Rubtsov DV, Lilley KS. Comparison of DIGE and post-stained gel electrophoresis with both traditional and SameSpots analysis for quantitative proteomics. Proteomics. 2008; 8(5): 948960.
  • 17
    Zhang W, Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem. 2000; 72: 24822489.
  • 18
    Friedman JH. Multivariate adaptive regression splines. Annal Statist. 1991; 19(1): 167.
  • 19
    Bozza F, Cruz O, Zagne S, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis. 2008; 8(1): 86.
  • 20
    Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, Cabrera MV, Rodriguez R, Rosario D, Martinez E, Denny T, Guzman MG. IL-10 levels in dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol. 2004; 73(2): 230234.
  • 21
    Tyagarajan K, Pretzer EP, Wiktorowicz JE. Thiol-reactive dyes for fluorescence labeling of proteomic samples. Electrophoresis. 2003; 24: 23482358.
  • 22
    Cook NR, Zee RYL, Ridker PM. Tree and spline based association of gene-gene interaction models for ischemic stroke. Statist Med. 2005; 23: 14391453.
  • 23
    Fawcett T. An introduction to ROC analysis. Pattern Recog Lett. 2006; 27: 861874.
  • 24
    Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Radiology. 1982; 143: 2936.
  • 25
    Austin PC. A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality. Stat Med. 2007; 26(15): 29372957.
  • 26
    Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995; 4(3): 187196.
  • 27
    Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1(11): 845867.
  • 28
    Rifai N, Gerszten RE. Biomarker discovery and validation. Clin Chem. 2006; 52(9): 16351637.
  • 29
    Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin Appl. 2007; 1(1): 7388.
  • 30
    Seferovic MD, Krughkov V, Pinto D, Han VK, Gupta MB. Quantitative 2-D gel electrophoresis-based expression proteomics of albumin and IgG immunodepleted plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 865(1–2): 147152.
  • 31
    Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P. Correcting common errors in identifying cancer-specific serum peptide signatures. J Proteome Res. 2005; 4(4): 10601072.
  • 32
    Villanueva J, Nazarian A, Lawlor K, Yi SS, Robbins RJ, Tempst P. A sequence-specific exopeptidase activity test (SSEAT) for “functional” biomarker discovery. Mol Cell Proteomics. 2008; 7(3): 509518.
  • 33
    Tu C, Rudnick PA, Martinez MY, Cheek K, Stein SE, Slebos RJC, Liebler D. Depletion of abundant plasma proteins and limitations of plasma proteomics. J Proteome Res. 2010; 9(10): 49824991.
  • 34
    Brasier AR, Victor S, Ju H, Busse WW, Curran-Everett D, Bleecker ER, Castro M, Chung KF, Gaston B, Israel E, et al. Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines. Clin Transl Sci. 2010; 13: 147157.
  • 35
    Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis. 2004; 189: 9901000.
  • 36
    Green S, Rothman A. Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 2006; 19(5): 429436.
  • 37
    Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. 2007; 88(2): 365375.
  • 38
    Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010; 10(5): 338349.
  • 39
    Mitrakul C, Poshyachinda M, Futrakul P, Sangkawibha N, Ahandrik S. Hemostatic and platelet kinetic studies in dengue hemorrhagic fever. Am J Trop Med Hyg. 1977; 26: 975984.
  • 40
    Seneviratne SL, Malavige GN, de Silva HJ. Pathogenesis of liver involvement during dengue viral infections. Trans R Soc Trop Med Hyg. 2006; 100(7): 608614.
  • 41
    Villar-Centeno LA, Diaz-Quijano FA, Martinez-Vega RA. Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg. 2008; 78(3): 370374.
  • 42
    Srichaikul T, Nimmanitaya S, Artchararit N, Siriasawakul T, Sungpeuk P. Fibrinogen metabolism and disseminated intravascular coagulation in dengue hemorrhagic fever. Am J Trop Med Hyg. 1977; 26: 525532.
  • 43
    Albuquerque LM, Trugilho MRO, Chapeaurouge A, Jurgilas P, Bozza PT, Bozza FA, Perales J, Neves-Ferreira AGC. Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients. J Proteome Res. 2009; 8(12): 54315441.
  • 44
    Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006; 193(8): 10781088.
  • 45
    Thayan R, Huat TL, See LL, Tan CP, Khairullah NS, Yusof R, Devi S. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever. Trans R Soc Trop Med Hyg. 2009; 103(4): 413419.
  • 46
    Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz C, Miller SS, Su Q, McGrath A, Estock MA, Parmar P, et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics. 2003; 3(7): 13451364.